Aspire Biopharma Holdings, Inc. (ASBP)
6.65
+1.31
(+24.53%)
USD |
NASDAQ |
Jun 08, 16:00
6.21
-0.44
(-6.62%)
Pre-Market: 09:20
Aspire Biopharma Holdings SG&A Expense (Quarterly) : 1.355M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Resonate Blends, Inc. | 0.2615M |
| Kaya Holdings, Inc. | 0.073M |
| Bespoke Extracts, Inc. | 0.2881M |
| Earth Science Tech, Inc. | 1.622M |
| Eco-Growth Strategies, Inc. | 0.5899M |